# OnCo record tpst-4003 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/tpst-4003/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "tpst-4003" ;
  schema:name "TPST-4003"@en ;
  schema:description "TPST-4003 is a treatment from Tempest Therapeutics meant to turn a patient's T cells into cancer-hunting CAR-T cells inside the body, aimed at two markers on B cells and plasma cells."@en ;
  schema:url <https://onco.cc/drugs/tpst-4003/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://www.sec.gov/Archives/edgar/data/1544227/000119312526361240/d181522ds1.htm> ;
  onco:tag "pipeline" ;
  onco:modality "In vivo CAR-T (dual CD19 and BCMA)" ;
  onco:technologies <https://onco.cc/technologies/in-vivo-car-t/> ;
  onco:targets <https://onco.cc/targets/cd19/>, <https://onco.cc/targets/bcma/> ;
  onco:companies <https://onco.cc/companies/tempest-therapeutics/> .